These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 31725060)
21. HIV-Infected Ugandan Women on Antiretroviral Therapy Maintain HIV-1 RNA Suppression Across Periconception, Pregnancy, and Postpartum Periods. Matthews LT; Ribaudo HB; Kaida A; Bennett K; Musinguzi N; Siedner MJ; Kabakyenga J; Hunt PW; Martin JN; Boum Y; Haberer JE; Bangsberg DR J Acquir Immune Defic Syndr; 2016 Apr; 71(4):399-406. PubMed ID: 26495883 [TBL] [Abstract][Full Text] [Related]
22. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care. Maskew M; Jamieson L; Mohomi G; Long L; Mongwenyana C; Nyoni C; Mokaba D; Fox MP; Sanne I; Rosen S PLoS One; 2018; 13(8):e0201955. PubMed ID: 30161147 [TBL] [Abstract][Full Text] [Related]
23. HIV Care Continuum among Postpartum Women Living with HIV in Atlanta. Meade CM; Badell M; Hackett S; Mehta CC; Haddad LB; Camacho-Gonzalez A; Ford J; Holstad MM; Armstrong WS; Sheth AN Infect Dis Obstet Gynecol; 2019; 2019():8161495. PubMed ID: 30894788 [TBL] [Abstract][Full Text] [Related]
24. Population-level risk factors for vertical transmission of HIV in the national prevention of mother-to-child transmission programme in South Africa: An ecological analysis. Moyo F; Haeri Mazanderani A; Sherman GG; Kufa T S Afr Med J; 2022 Mar; 112(3):219-226. PubMed ID: 35380525 [TBL] [Abstract][Full Text] [Related]
25. Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study. Hosseinipour M; Nelson JAE; Trapence C; Rutstein SE; Kasende F; Kayoyo V; Kaunda-Khangamwa B; Compliment K; Stanley C; Cataldo F; van Lettow M; Rosenberg NE; Tweya H; Gugsa S; Sampathkumar V; Schouten E; Eliya M; Chimbwandira F; Chiwaula L; Kapito-Tembo A; Phiri S; J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2(Suppl 2):S149-S155. PubMed ID: 28498184 [TBL] [Abstract][Full Text] [Related]
26. Self-Reported Long-Term Antiretroviral Adherence: A Longitudinal Study Among HIV Infected Pregnant Women in Mpumalanga, South Africa. Ramlagan S; Rodriguez VJ; Peltzer K; Ruiter RAC; Jones DL; Sifunda S AIDS Behav; 2019 Sep; 23(9):2576-2587. PubMed ID: 31228026 [TBL] [Abstract][Full Text] [Related]
27. Maternal Motivation to Take Preventive Therapy in Antepartum and Postpartum Among HIV-Positive Pregnant Women in South Africa: A Choice Experiment. Kim HY; Dowdy DW; Martinson NA; Kerrigan D; Tudor C; Golub J; Bridges JFP; Hanrahan CF AIDS Behav; 2019 Jul; 23(7):1689-1697. PubMed ID: 30415430 [TBL] [Abstract][Full Text] [Related]
28. More Frequent HIV Viral Load Testing With Point-Of-Care Tests Detects Elevated Viral Load Earlier in Postpartum HIV-Positive Women in a Randomized Controlled Trial in Two Clinics in Johannesburg, South Africa. Fairlie L; Sawry S; Pals S; Sherman G; Williamson D; Le Roux J; Ngeno B; Berrie L; Diallo K; Cox MH; Mogashoa M; Chersich M; Modi S; J Acquir Immune Defic Syndr; 2023 Dec; 94(5):412-420. PubMed ID: 37949444 [TBL] [Abstract][Full Text] [Related]
29. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study. le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459 [TBL] [Abstract][Full Text] [Related]
30. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa. Fox MP; Pascoe S; Huber AN; Murphy J; Phokojoe M; Gorgens M; Rosen S; Wilson D; Pillay Y; Fraser-Hurt N PLoS Med; 2019 Jul; 16(7):e1002874. PubMed ID: 31335865 [TBL] [Abstract][Full Text] [Related]
31. Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya. Larson BA; Bii M; Halim N; Rohr JK; Sugut W; Sawe F PLoS One; 2018; 13(8):e0200199. PubMed ID: 30096177 [TBL] [Abstract][Full Text] [Related]
32. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe. Erlwanger AS; Joseph J; Gotora T; Muzunze B; Orne-Gliemann J; Mukungunugwa S; Farley T; Mangwiro AZ J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S198-S206. PubMed ID: 28498190 [TBL] [Abstract][Full Text] [Related]
33. A systematic review of health system barriers and enablers for antiretroviral therapy (ART) for HIV-infected pregnant and postpartum women. Colvin CJ; Konopka S; Chalker JC; Jonas E; Albertini J; Amzel A; Fogg K PLoS One; 2014; 9(10):e108150. PubMed ID: 25303241 [TBL] [Abstract][Full Text] [Related]
34. ART history prior to conception: trends and association with postpartum disengagement from HIV care in Khayelitsha, South Africa (2013-2019): a retrospective cohort study. Phillips TK; Kassanjee R; Maxwell N; Anderson K; Johnson L; Moolla H; Myer L; Chi BH; Euvrard J; Boulle A; Davies MA; Cornell M; de Waal R J Int AIDS Soc; 2024 Apr; 27(4):e26236. PubMed ID: 38566482 [TBL] [Abstract][Full Text] [Related]
35. The South African National HIV Pregnancy Cohort: evaluating continuity of care among women living with HIV. Clouse K; Malope-Kgokong B; Bor J; Nattey C; Mudau M; Maskew M BMC Public Health; 2020 Nov; 20(1):1662. PubMed ID: 33153468 [TBL] [Abstract][Full Text] [Related]
36. Conditional Cash Transfers to Increase Retention in PMTCT Care, Antiretroviral Adherence, and Postpartum Virological Suppression: A Randomized Controlled Trial. Yotebieng M; Thirumurthy H; Moracco KE; Edmonds A; Tabala M; Kawende B; Wenzi LK; Okitolonda EW; Behets F J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 2(Suppl 2):S124-9. PubMed ID: 27355499 [TBL] [Abstract][Full Text] [Related]
37. Frequency of Viremic Episodes in HIV-Infected Women Initiating Antiretroviral Therapy During Pregnancy: A Cohort Study. Myer L; Dunning L; Lesosky M; Hsiao NY; Phillips T; Petro G; Zerbe A; McIntyre JA; Abrams EJ Clin Infect Dis; 2017 Feb; 64(4):422-427. PubMed ID: 27927852 [TBL] [Abstract][Full Text] [Related]
38. A systematic review of individual and contextual factors affecting ART initiation, adherence, and retention for HIV-infected pregnant and postpartum women. Hodgson I; Plummer ML; Konopka SN; Colvin CJ; Jonas E; Albertini J; Amzel A; Fogg KP PLoS One; 2014; 9(11):e111421. PubMed ID: 25372479 [TBL] [Abstract][Full Text] [Related]
39. Increased Access to Antiretroviral Therapy Is Associated with Reduced Maternal Mortality in Johannesburg, South Africa: An Audit from 2003-2012. Black V; Black AD; Rees HV; Guidozzi F; Scorgie F; Chersich MF PLoS One; 2016; 11(12):e0168199. PubMed ID: 28033409 [TBL] [Abstract][Full Text] [Related]
40. SMS messaging to improve retention and viral suppression in prevention of mother-to-child HIV transmission (PMTCT) programs in Kenya: A 3-arm randomized clinical trial. Kinuthia J; Ronen K; Unger JA; Jiang W; Matemo D; Perrier T; Osborn L; Chohan BH; Drake AL; Richardson BA; John-Stewart G PLoS Med; 2021 May; 18(5):e1003650. PubMed ID: 34029338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]